What does this research mean for the field?

SLC25A39 is overexpressed in most cancer types, serves as an unfavorable prognostic biomarker associated with immune infiltration, and exerts pro-tumorigenic effects that drive cancer cell proliferation. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This research aims to profile SLC25A39 across various cancers and evaluate its prognostic significance and molecular mechanisms.

July 28, 2026Discover OncologyOpen Access

Bioinformatic characterization of SLC25A39 across cancers with validation in hepatocellular carcinoma

View Full Paper

Ask AI

Bookmark

This research aims to profile SLC25A39 across various cancers and evaluate its prognostic significance and molecular mechanisms.
Conducted multi-omics analysis of SLC25A39 in cancer types using existing databases.
Validated findings through in vitro gene knockdown experiments in hepatocellular carcinoma cell lines.
Evaluated associations with immune cell infiltration and key cancer-related pathways.
SLC25A39 was predominantly overexpressed in almost all cancer types, serving as an unfavorable prognostic marker.
Knockdown of SLC25A39 significantly inhibited hepatocellular carcinoma cell proliferation.
Expression levels were significantly linked to immune microenvironment factors like immune checkpoints and tumor mutation burden.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Randomized trial demonstrates the prognostic relevance of SLC25A39 in hepatocellular carcinoma, suggesting its role as a potential biomarker.

Cite This Study

Qin et al. (2026) studied this question.

synapsesocial.com/papers/6a6850eb2845b684d16f0084 https://doi.org/10.1007/s12672-026-05621-w

View Full Paper

Ask AI

Bookmark

Implication

Randomized trial demonstrates the prognostic relevance of SLC25A39 in hepatocellular carcinoma, suggesting its role as a potential biomarker.

Bioinformatic characterization of SLC25A39 across cancers with validation in hepatocellular carcinoma

Key Points

Discussion

Implication

Cite This Study

Bioinformatic characterization of SLC25A39 across cancers with validation in hepatocellular carcinoma

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider